The risk of COVID-19 infection in patients with atopic dermatitis: A retrospective cohort study
J Am Acad Dermatol
.
2022 Jan;86(1):243-245.
doi: 10.1016/j.jaad.2021.09.061.
Epub 2021 Oct 6.
Authors
Jashin J Wu
1
,
Amylee Martin
2
,
Jeffrey Liu
3
,
Akshitha Thatiparthi
4
,
Shaokui Ge
2
,
Alexander Egeberg
5
,
Jacob P Thyssen
5
Affiliations
1
Dermatology Research and Education Foundation, Irvine, California. Electronic address: jashinwu@hotmail.com.
2
School of Medicine, University of California, Riverside, California.
3
Keck School of Medicine, University of Southern California, Los Angeles, California.
4
Western University of Health Sciences, Pomona, California.
5
Department of Dermatology, Bispebjerg University Hospital, University of Copenhagen, Copenhagen, Denmark.
PMID:
34626733
PMCID:
PMC8492899
DOI:
10.1016/j.jaad.2021.09.061
No abstract available
Keywords:
COVID-19; atopic dermatitis; dupilumab; epidemiology; infection.
MeSH terms
COVID-19* / epidemiology
Dermatitis, Atopic* / epidemiology
Humans
Retrospective Studies